RBM15 silencing promotes ferroptosis by regulating the TGF-β/Smad2 pathway in lung cancer

Objective: We assessed the function and mechanism of RNA binding motif protein 15 (RBM15) silencing in lung cancer development.Methods: The effects of RBM15 knockdown on A549 and H1299 cells were evaluated by MTT, EdU, wound healing, and transwell assay. We then detected the functions of RBM15 silencing on lipid peroxidation, labile iron pool (LIP), ferrous iron (Fe2+), and ferroptosis-related genes. RNA sequencing was performed after RBM15 knockout in lung cancer cells, followed by differentially expressed genes (DEGs), Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis were performed. Finally, the expression of RBM15 and pathway-related genes was determined by western blot.Results: RBM15 was highly expressed in lung cancer cells. RBM15 silencing reduced the viability, inhibited cell proliferation, invasion, and migration, and suppressed tumor growth in the xenograft mouse model. Knockout of RBM15 regulated ferroptosis-related gene expression. LIP, Fe2+, and lipid peroxidation were distinctly increased by the knockout of RBM15. RNA-seq sequencing revealed that there are 367 up-regulated and 368 down-regulated DEGs, which were enriched in molecular functions, biological processes, and cellular components. RBM15 silencing reduced the expression of TGF-beta/Smad2, and TGF-beta activator (SRI-011381) reversed the inhibitory effect of RBM15 silencing on tumor cell growth.Conclusion: We demonstrated that RBM15 silencing promoted ferroptosis in lung cancer cells by TGF-beta/Smad2 pathway, thereby inhibiting lung cancer cell growth, which may provide new light for lung cancer treatment.

Automated summary

This study assessed the function and mechanism of RNA binding motif protein 15 (RBM15) silencing in lung cancer development. The results showed that RBM15 silencing promoted ferroptosis in lung cancer cells through the TGF-beta/Smad2 pathway, thereby inhibiting lung cancer cell growth and metastasis.